PCV41 A COST CONSEQUENCE ANALYSIS OF THE IMPACT OF JBS 2 ON PATIENTS ELIGIBLE FOR STATIN TREATMENT IN SCOTLAND
Nov 1, 2006, 00:00 AM
10.1016/S1098-3015(10)63657-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)63657-1/fulltext
Section Title :
Section Order :
508
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63657-1&doi=10.1016/S1098-3015(10)63657-1